CN109481599A - 一种降低血脂血压的花果茶及制备方法 - Google Patents
一种降低血脂血压的花果茶及制备方法 Download PDFInfo
- Publication number
- CN109481599A CN109481599A CN201811602193.2A CN201811602193A CN109481599A CN 109481599 A CN109481599 A CN 109481599A CN 201811602193 A CN201811602193 A CN 201811602193A CN 109481599 A CN109481599 A CN 109481599A
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- blood pressure
- scented tea
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 title claims abstract description 34
- 230000036772 blood pressure Effects 0.000 title claims abstract description 21
- 230000001603 reducing effect Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims description 10
- 241001122767 Theaceae Species 0.000 title description 38
- 235000013616 tea Nutrition 0.000 claims abstract description 46
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 22
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 22
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 22
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 22
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 22
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 22
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 22
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 22
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 22
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 22
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 22
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 17
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 17
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 17
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 17
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 17
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 17
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 16
- 239000009636 Huang Qi Substances 0.000 claims abstract description 15
- 239000009759 San-Chi Substances 0.000 claims abstract description 14
- 208000031226 Hyperlipidaemia Diseases 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 206010020772 Hypertension Diseases 0.000 claims abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims abstract 7
- 235000013399 edible fruits Nutrition 0.000 claims description 22
- 240000002853 Nelumbo nucifera Species 0.000 claims description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 14
- 240000000249 Morus alba Species 0.000 claims description 12
- 235000008708 Morus alba Nutrition 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 239000012535 impurity Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000006468 Thea sinensis Nutrition 0.000 claims description 7
- 235000020333 oolong tea Nutrition 0.000 claims description 7
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 235000020339 pu-erh tea Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 20
- 230000001631 hypertensive effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 150000002632 lipids Chemical class 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 7
- 230000036541 health Effects 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 244000201986 Cassia tora Species 0.000 description 4
- 235000014552 Cassia tora Nutrition 0.000 description 4
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 235000003143 Panax notoginseng Nutrition 0.000 description 3
- 241000180649 Panax notoginseng Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000003212 lipotrophic effect Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- RYHZSFNAGFOCEZ-PYXKSNNZSA-N (2r,3r,4s,5s,6r)-4-[(3r,4s,5s,6r)-6-[[(2r,3r,4s,5s,6r)-4-[(2s,3r,4s,5r,6r)-6-[[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4-[(3r,4s,5r,6r)-6-[[(2r,3 Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@H](OC[C@@H]3[C@@H]([C@H](OC4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@H]5[C@@H]([C@@H](O[C@H]6[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@H]7[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O7)O)O6)O)[C@@H](O)[C@@H](CO)O5)O)O4)O)[C@@H](O)C(O[C@H]4[C@H]([C@@H](CO)O[C@@H](O)[C@@H]4O)O)O3)O)O[C@H](CO)[C@@H]2O)O)O1 RYHZSFNAGFOCEZ-PYXKSNNZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000031288 Combined hyperlipidaemia Diseases 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 244000224182 Gomphrena globosa Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 235000019083 Osmanthus fragrans Nutrition 0.000 description 1
- 244000242564 Osmanthus fragrans Species 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 241000132004 Symphyotrichum cordifolium Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 244000172533 Viola sororia Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种降低血脂血压的花果茶,由如下原料按重量配比制成:菊花15~20份、金银花10~15份、山楂5~10份、焦山楂5~10份、决明子3~5份、何首乌3~5份、三七花3~5份、黄芪1~3份。该茶能够有效对高血脂和高血压病人有明显疗效,能够有效降低血脂血压,见效快,而且口感好,深受欢迎。
Description
技术领域
本发明涉及一种花果茶组合物,具体涉及一种降低血脂血压的花果茶及其制备方法。
背景技术
花果茶是一种草本饮料,其由植物的根、茎、皮、花、枝、果实、种籽、叶等制成,在煎煮或冲泡后饮用。花果茶原料中的植物成份具有营养保健的作用,并且往往可以协同作用、相互影响,有助于调整人体生理机能,保持健康。如发明专利CN102342352B公开了一种养生花果茶及其制备方法,该花果茶包括贡菊、山楂、千日红、百里香、桂花、金盏花、紫罗兰、香蜂草、梨子、柠檬、李子、杏、迷迭香等组分,虽然上述专利的花果茶具备养生功效,但降血脂功效甚微。血脂是血液中所含类脂质的总称,血脂中主要包含胆固醇、甘油三脂、磷脂和脂肪酸等。高血脂是指血脂水平过高,可直接引起一些严重危害人类身体健康的疾病,如动脉粥样硬化、冠心病、胰腺炎等,是当今社会的流行病之一。高血脂对身体的损害是隐匿、逐渐、进行性和全身性的,它的直接损害是加速全身动脉粥样硬化,而全身的重要器官都要依靠动脉供血、供氧,一旦动脉被粥样斑块堵塞,就会导致严重后果。高血脂症是脑卒中、冠心病、心肌梗死和心脏猝死等重要的危险因素。发明专利申请CN107980990A公开了一种降血脂的花果茶及其制备方法,包括茉莉花、金银花、三七、首乌、苦瓜、玉米、洋葱、苹果、葡萄、甜菊叶等组分,该花果茶虽然具有一定的降低胆固醇以及预防心血管疾病等功效,但在见效较慢,不能令人满意。
发明内容
本发明的目的是提供一种降低血脂血压的花果茶,该茶能够有效对高血脂和高血压病人有明显疗效,能够有效降低血脂血压,见效快,而且口感好,深受欢迎。
为了实现上述目的,本发明采取如下技术方案:
一种降低血脂血压的花果茶,由如下原料按重量配比制成:菊花15~20份、金银花10~15份、山楂5~10份、焦山楂5~10份、决明子3~5份、何首乌3~5份、三七花3~5份、黄芪1~3份。
优选的,该花果茶还包括如下按重量计的辅料:所述辅料成分包括:枸杞子1~2份、桑椹3~5份、荷叶1~2份、薏米3~5份、陈皮1~2份和乌龙茶或普洱茶3~5份。
本发明另一个目的是提供上述花果茶的制备方法:
上述降低血脂血压的花果茶的制备方法,其特征在于包括如下步骤:
(1)将菊花、金银花、何首乌、三七花、黄芪、荷叶、陈皮清水浸泡5分钟,清洗干净,去除杂质,滤水后烘干备用;
(2)将山楂、枸杞子、桑椹清洗干净,去除杂质,滤水后烘干备用;
(3)将决明子炒制,冷却;
(4)将薏米浸泡5-10分钟,清洗干净,去除杂质,滤水后烘干炒制备用;
(5)将所述各原料混合,用破壁机破碎、制得混合花果茶,然后灭菌、封装,得到降脂降压花果茶成品。
本发明再一个目的是提供上述花果茶在治疗或辅助治疗高血脂或高血压病中的应用。
与现有技术中的其它药剂或饮品例如他汀类药物、山楂水或决明子茶等相比,本发明的花果茶口感好,在降低胆固醇、甘油三脂、低密度脂蛋白,升高高密度脂蛋白,增加开胃消食感、大便通畅感,减轻眼花症状和脂肪肝程度等方面,具有显著的功效。
本发明利用药食同源作用,以食材为主,药材为辅,将天然食材与药材相结合,选择健康食材与临床验方组合,饮用安全,无毒无害,利于健康,能有效地降低血脂和/或降低血压。同时严格按照甄选药材的标准进行食材选料,确保食材与药材质量优良。组方搭配合理,每个单方数量充足,以人为本,防治结合。药材使用量则以最低起始量,既保证药物药量起效,又避免了因药物过量引起毒副作用之风险。
现代药理研究表明:菊花具有治疗冠心病、降低血压、预防高血脂、抗菌、抗病毒、抗炎、抗衰老等多种药理活性。
其预防各种感染、降血脂、降血压、预防动脉硬化及冠心病的功效。此外,还有清肝明目、散风清热是菊花茶的最大优势。
金银花具有抑菌、抗病毒、抗炎、解热、调节免疫等作用。
芳香的金银花是我国古老的药物,素有“药铺小神仙”之誉。清热解毒的功能尤为突出。
山楂和焦山楂具有消食化积,收敛止泻,行气散瘀的功效。能够降低血脂,具有很好的减肥作用,适用于痰湿阻滞,气滞血瘀导致的肥胖。
山楂和焦山楂有抗癌、抗菌、增强心肌收缩、降压、降血脂、降胆固醇、利尿、抗动脉硬化、所含脂肪酶能促进脂肪分解和加强消化代谢功能。
决明子具有清热明目,润肠通便的功效。
决明子具有降血压、降血脂、降胆固醇、保肝、润肠通便和促进胃液分泌的作用。
三七花具有清热、平肝、镇静安神、抗炎镇痛、降血压等药理作用。能够扩张动脉,改善血液循环,起到调理经络,降低血压的作用,同时还能调理肝脏,对于高血压等病有很好的防治作用。
三七能够提高机体的免疫能力,可显著提高小鼠腹腔巨噬细胞的吞噬率和吞噬指数。其中,三七多糖A能明显降低自然杀伤细胞(NKC)活性,药物剂量加大时抑制作用加强。
何首乌具有解毒,消痈,润肠通便、补肝,益肾,养血,祛风的功效。
何首乌具有降血脂的作用,给家兔同时喂饲何首乌和胆甾醇,其所形成的动脉粥样病变较单喂胆甾醇之对照组轻,血清胆甾醇水平亦较低,体外试验何首乌能与胆甾醇结合,在兔肠道能减少胆甾醇的吸收;还具有降血糖的作用。
黄芪是补气中的要药。具有补气开阳,固表止汗,托疮生肌、利水退肿之功效。
现代药理研究表明:黄芪含黄芪皂苷类物质及多种氨基酸和硒、硅、钴、钼等微量元素,其他成分还包括香豆素、叶酸、香菜碱、亚油酸、β-谷甾醇等多种化学成分,具有多种药理作用。
黄芪可双向调节免疫功能,促进蛋白质合成,减少蛋白质漏出,通过扩张血管、降低血压增加肾血流量,调节肾小球滤过膜,减少蛋白尿渗出,减轻或延缓糖尿病性肾病的进展。
枸杞子具有抗脂肪肝的作用,有抑制脂肪在肝细胞内沉积,促进肝细胞新生的作用。枸杞子对脂质代谢或抗脂肪肝的作用,主要是由于其中所含的甜菜碱所引起,甜菜碱在体内起甲基供应体的作用。
桑椹具有滋阴补血、明目生津,润燥的功能。
桑椹有提高免疫力、降血糖、降血脂、抗炎、抗衰老、防癌抗突变、促进造血细胞生长等作用。
荷叶具有清暑利湿,生发清阳,清心去热,止血利水,健脾的功效。
临床上荷叶已广泛用于肥胖症和高脂血症,并取得了较好的疗效,但多散在复方中,而且制剂仅限于粗加工,较少对荷叶的有效部位进行深入研究。
近年来各项研究表明:荷叶及其提取物都具有去脂减肥的作用。
综上所述,菊花、山楂、焦山楂、决明子、三七花或三七、何首乌、荷叶、乌龙茶组分配伍,可以起到相互协同叠加降低血脂,降低血压,消食化瘀,通经活络,改善血液循环,抗动脉粥样硬化的功能;同时,在配伍金银花、枸杞子、黄芪、桑椹组分则可清热解毒,增强免疫,滋补肝肾,降糖,防癌等多种保健功效。为此,整体起到降低血脂降低血压的作用,而且见效快、疗效显著。
具体实施方式
下面通过具体实施例对本发明做进一步说明,以下一份为10克。
实施例1:花果茶配方1
菊花15份、金银花10份、山楂5份、焦山楂5份、决明子3份、何首乌3份、三七花3份、黄芪1份。
实施例2:花果茶配方2
菊花20份、金银花15份、山楂10份、焦山楂10份、决明子5份、何首乌5份、三七花5份、黄芪3份。
实施例3:花果茶配方3
菊花18份、金银花12份、山楂8份、焦山楂8份、决明子4份、何首乌4份、三七花4份、黄芪2份。
实施例4:花果茶配方4
菊花15份、金银花15份、山楂10份、焦山楂5份、决明子3份、何首乌3份、三七花5份、黄芪1份、枸杞子1份、桑椹3份、荷叶1份、薏米3份、陈皮1份和乌龙茶或普洱茶5份。
实施例5:花果茶配方5
菊花20份、金银花10份、山楂5份、焦山楂10份、决明子5份、何首乌5份、三七花3份、黄芪3份、枸杞子2份、桑椹5份、荷叶2份、薏米5份、陈皮2份和乌龙茶或普洱茶3~5份、枸杞子1~2份、桑椹3~5份、荷叶1~2份、薏米3~5份、陈皮1~2份和乌龙茶或普洱茶3份。
实施例6:花果茶配方6
菊花18份、金银花14份、山楂7份、焦山楂6份、决明子4份、何首乌4份、三七花4份、黄芪2份、枸杞子1.5份、桑椹4份、荷叶1.5份、薏米4份、陈皮1.5份和乌龙茶或普洱茶4份。
实施例7:上述花果茶的制备方法
(1)将菊花、金银花、何首乌、三七花、黄芪、荷叶、陈皮清水浸泡5分钟,清洗干净,去除杂质,滤水后烘干备用;
(2)将山楂、枸杞子、桑椹清洗干净,去除杂质,滤水后烘干备用;
(3)将决明子炒制,冷却;
(4)将薏米浸泡5-10分钟,清洗干净,去除杂质,滤水后烘干炒制备用;
(5)将所述各原料混合,用破壁机破碎、制得混合花果茶,然后灭菌、封装,得到降压降脂花果茶成品。
实施例8:本产品使用效果1
2012年7月至2018年2月期间,选择患者600名,入选标准:血脂异常、高脂血症(高甘油三酯血症、高胆固醇血症、低高密度脂蛋白血症、混合性高脂血症)、血液粘稠、肥胖、脂肪肝、高血压、正常高值等。临床检查血浆甘油三酯、胆固醇、低密度脂蛋白单纯和或混合升高,高密度脂蛋白正常或降低患者。
分为花果茶实验组和对照组,每组各300名。
实验组:将本发明花果茶制成茶水供患者饮用,在实验期间坚持饮用。
对照组:给对照组的患者分别施用他汀类药物、山楂水或决明子茶,在实验期间坚持饮用。
实验结束后,观察并统计实验组和对照组的症状缓解状况,结果如下表1所示。
实施例9:本产品使用效果2
给五名患者使用本品并定期监测生化指标,结果如表2所示,由表2可见,五名患者通过服用本品生化指标得到改善,身体状况得到康复。
患者1,张某,38岁,男
患者2,武某,41岁,男
患者3,孙某,39岁,男
患者4,岳某,53岁,男
患者5,董某,36岁,男
表1. 本发明的菊花山楂决明茶的降血脂/降血压效果
从上面标的结果可以看出,与分别施用他汀类药物、山楂水或决明子茶的对照组相比,饮用本发明的菊花山楂决明茶的实验组在降低胆固醇、甘油三脂、低密度脂蛋白,升高高密度脂蛋白,增加开胃消食感、大便通畅感,减轻眼花症状和脂肪肝程度方面,体现了显著的效果。
另外,在治疗过程中,92%的患者认为本发明的花果茶口感好,而只有约37%的患者认为对照组的他汀类药物、山楂水或决明子茶口感好。
上述实施例只是对本发明构思和实现的说明,并非对其进行限制,在本发明构思下,未经实质变换的技术方案仍然在保护范围内。
Claims (4)
1.一种降低血脂血压的花果茶,其特征在于由如下原料按重量配比制成:菊花15~20份、金银花10~15份、山楂5~10份、焦山楂5~10份、决明子3~5份、何首乌3~5份、三七花3~5份、黄芪1~3份。
2.如权利要求1所述的降低血脂血压的花果茶,其特征在于还包括如下按重量计的辅料:所述辅料成分包括:枸杞子1~2份、桑椹3~5份、荷叶1~2份、薏米3~5份、陈皮1~2份和乌龙茶或普洱茶3~5份。
3.如权利要求1或2所述的降低血脂血压的花果茶的制备方法,其特征在于包括如下步骤:
(1)将菊花、金银花、何首乌、三七花、黄芪、荷叶、陈皮清水浸泡5分钟,清洗干净,去除杂质,滤水后烘干备用;
(2)将山楂、枸杞子、桑椹清洗干净,去除杂质,滤水后烘干备用;
(3)将决明子炒制,冷却;
(4)将薏米浸泡5-10分钟,清洗干净,去除杂质,滤水后烘干炒制备用;
(5)将所述各原料混合,用破壁机破碎、制得混合花果茶,然后灭菌、封装,得到降脂降压花果茶成品。
4.如权利要求1或2所述的降低血脂血压的花果茶在治疗或辅助治疗高血脂或高血压病中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811602193.2A CN109481599A (zh) | 2018-12-26 | 2018-12-26 | 一种降低血脂血压的花果茶及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811602193.2A CN109481599A (zh) | 2018-12-26 | 2018-12-26 | 一种降低血脂血压的花果茶及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109481599A true CN109481599A (zh) | 2019-03-19 |
Family
ID=65712344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811602193.2A Pending CN109481599A (zh) | 2018-12-26 | 2018-12-26 | 一种降低血脂血压的花果茶及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109481599A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744072A (zh) * | 2008-11-27 | 2010-06-23 | 陶俊才 | 黄芪养生茶 |
CN101755970A (zh) * | 2008-12-01 | 2010-06-30 | 严志萍 | 一种降血压保健茶 |
CN105432871A (zh) * | 2014-09-29 | 2016-03-30 | 吴同忠 | 用于治疗肥胖症的山楂银菊茶 |
-
2018
- 2018-12-26 CN CN201811602193.2A patent/CN109481599A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744072A (zh) * | 2008-11-27 | 2010-06-23 | 陶俊才 | 黄芪养生茶 |
CN101755970A (zh) * | 2008-12-01 | 2010-06-30 | 严志萍 | 一种降血压保健茶 |
CN105432871A (zh) * | 2014-09-29 | 2016-03-30 | 吴同忠 | 用于治疗肥胖症的山楂银菊茶 |
Non-Patent Citations (4)
Title |
---|
一所: "《天涯问答》", 9 April 2010, HTTP://WENDA.TIANYA.CN/ANSWER/3900418DF172CB43000474188CAD5C6C * |
张君波,等: "自拟九味茶治疗代谢综合征临床观察", 《上海中医药杂志》 * |
麻兵继,等: "八味丹参茶中丹参酚酸B和总丹参酮的含量测定", 《中国药师》 * |
黄昏AEC: "《百度知道》", 26 September 2014, HTTPS://ZHIDAO.BAIDU.COM/QUESTION/918586591231702819.HTML * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101011561B (zh) | 黄连温胆汤现代中药口服制剂及其生产方法 | |
CN101485830B (zh) | 一种中药抗衰老保健胶囊 | |
CN102000299B (zh) | 一种治疗高脂血症的药物 | |
CN102451363A (zh) | 中草药减肥茶 | |
CN102273531B (zh) | 芪皇养生茶与芪皇养生胶囊 | |
CN102687773A (zh) | 一种养肝保健茶 | |
CN104758806A (zh) | 一种治疗冠心病的煎膏剂及其制备方法 | |
CN102366605A (zh) | 一种治疗高血压高血脂的中药制剂及制备方法 | |
CN101755970A (zh) | 一种降血压保健茶 | |
CN1907386B (zh) | 一种用于治疗高血脂症、高血压、冠心病的中药组合物 | |
CN105106446A (zh) | 一种用于降血压的保健茶及其制备方法 | |
CN108355055A (zh) | 一种用于治疗高血压的药物组合物 | |
CN109481599A (zh) | 一种降低血脂血压的花果茶及制备方法 | |
CN103431380A (zh) | 一种降低心肌耗氧及增加冠脉血流量的食疗产品 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN101934060B (zh) | 一种治疗高血压的药物 | |
CN100355434C (zh) | 一种防治心脑血管疾病的药物 | |
CN104721092A (zh) | 一种含银杏叶水提剂的沐浴液及其制备方法 | |
CN104800600A (zh) | 一种治疗高血压的药物 | |
CN1146288A (zh) | 中药茶 | |
CN104799276B (zh) | 一种麻七利血溶栓粉及其制备方法 | |
CN104740345B (zh) | 治疗糖尿病的中药组合物及其制备方法 | |
CN114767794B (zh) | 一种治疗动脉斑块的中药 | |
CN102145085A (zh) | 防治高脂血症的中药保健茶 | |
CN102047990A (zh) | 防治高脂血症的中药保健茶 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190319 |
|
RJ01 | Rejection of invention patent application after publication |